Minji Kim
Corporate Officer/Principal at MINERALYS THERAPEUTICS, INC.
Profile
Minji Kim is currently the Chief Business Officer at Mineralys Therapeutics, Inc. Prior to this, she worked as the Vice President of Corporate and Business Development at Curis, Inc. and as an Associate in Global Business Development and Licensing at Hoffmann-La Roche, Inc. She holds a Master's in Business Administration from Yale University and a doctorate from Seoul National University.
Minji Kim active positions
| Companies | Position | Start |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Corporate Officer/Principal | 2024-01-03 |
Former positions of Minji Kim
| Companies | Position | End |
|---|---|---|
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| CURIS, INC. | Corporate Officer/Principal | - |
Training of Minji Kim
| Seoul National University | Doctorate Degree |
| Yale University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CURIS, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Stock Market
- Insiders
- Minji Kim